Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers

Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)

NCT05087368 ·Status: UNKNOWN ·Phase: PHASE2

Safety and Immunogenicity of a SARS-CoV-2 Vaccine (NBP2001) in Healthy Adults (COVID-19)

NCT04760743 ·Status: COMPLETED ·Phase: PHASE1

Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)

NCT05007951 ·Status: COMPLETED ·Phase: PHASE3

Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2（COVID-19） Phase I Clinical Trial (3~17 Years Old)

NCT04961359 ·Status: COMPLETED ·Phase: PHASE1

COVID-19 Oral and Subcutaneous Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenovirus Platform in Healthy Volunteers in USA

NCT04732468 ·Status: TERMINATED ·Phase: PHASE1

Evaluation of Safety and Immunogenicity of a Novel Vaccine for Prevention of Covid-19 in Adults Previously Immunized

NCT05016934 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2

Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)

NCT05633446 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19

NCT04619628 ·Status: COMPLETED ·Phase: PHASE1

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

NCT04636697 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3

Dose Escalation Study to Evaluate the Safety and Immunogenicity of the Cholera Conjugate Vaccine in Healthy Adults

NCT05559983 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerance and Immunogenicity of EuCorVac-19 for the Prevention of COVID-19 in Healthy Adults

NCT04783311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

COVID-19 VACCINE SAFETY AND EFFECTIVENESS

NCT05133609 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Recombinant New Coronavirus Vaccine (CHO Cells) to Prevent SARS-CoV-2 Phase I Clinical Trial (≥60 Years Old)

NCT04550351 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

NCT07300839 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

AZD1222 Vaccine for the Prevention of COVID-19

NCT04540393 ·Status: WITHDRAWN ·Phase: PHASE3

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

NCT04516746 ·Status: COMPLETED ·Phase: PHASE3

A Clinical Trial to Evaluate the Recombinant SARS-CoV-2 Vaccine (CHO Cell) for COVID-19

NCT04869592 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immunogenicity and Safety Study of One Booster Dose of Trivalent COVID-19 Vaccine (Vero Cell), Inactivated

NCT05433272 ·Status: UNKNOWN ·Phase: PHASE3

COVID19 Vaccination: Clinical, Laboratory and Cellular Monitoring

NCT04844632 ·Status: UNKNOWN

Safety and Immunogenicity of COVI-VAC as a Booster Dose in Adults Previously Vaccinated Against COVID-19

NCT05233826 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Safety, Immunogenicity, and Efficacy of Nanocovax Vaccine Against COVID-19

NCT04922788 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)

NCT05109598 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess Safety, Reactogenicity and Immunogenicity of the VACCINE RNA MCTI CIMATEC HDT (HDT-301) Vaccine Against COVID-19

NCT04844268 ·Status: UNKNOWN ·Phase: PHASE1

Safety and Immunogenicity Study of Booster Vaccination With COVID-19 Vaccine (Vero Cell),Inactivated From Different Manufactures for Prevention of COVID-19

NCT05165732 ·Status: SUSPENDED ·Phase: PHASE4

Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention

NCT04686773 ·Status: COMPLETED ·Phase: PHASE2